124 related articles for article (PubMed ID: 1707628)
1. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
Patel KV; Schrey MP
J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
[TBL] [Abstract][Full Text] [Related]
2. Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth.
Bepler G; Zeymer U; Mahmoud S; Fiskum G; Palaszynski E; Rotsch M; Willey J; Koros A; Cuttitta F; Moody TW
Peptides; 1988; 9(6):1367-72. PubMed ID: 2470067
[TBL] [Abstract][Full Text] [Related]
3. Potent bombesin receptor antagonists distinguish receptor subtypes.
von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
[TBL] [Abstract][Full Text] [Related]
4. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
Jensen RT; Heinz-Erian P; Mantey S; Jones SW; Gardner JD
Am J Physiol; 1988 Jun; 254(6 Pt 1):G883-90. PubMed ID: 2454035
[TBL] [Abstract][Full Text] [Related]
5. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells.
Severi C; Coy DH; Jensen RT; Boschero L; Anania MC; Delle Fave G
J Pharmacol Exp Ther; 1989 Nov; 251(2):713-7. PubMed ID: 2478696
[TBL] [Abstract][Full Text] [Related]
7. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
Woll PJ; Rozengurt E
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
[TBL] [Abstract][Full Text] [Related]
8. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
9. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
Amiot F; Leiber D; Marc S; Harbon S
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
[TBL] [Abstract][Full Text] [Related]
10. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
11. [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells.
Seckl MJ; Higgins T; Rozengurt E
J Biol Chem; 1996 Nov; 271(46):29453-60. PubMed ID: 8910612
[TBL] [Abstract][Full Text] [Related]
12. Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressin.
Woll PJ; Rozengurt E
Growth Factors; 1988; 1(1):75-83. PubMed ID: 2483337
[TBL] [Abstract][Full Text] [Related]
13. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
14. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.
Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612
[TBL] [Abstract][Full Text] [Related]
15. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
[TBL] [Abstract][Full Text] [Related]
16. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
Mahmoud S; Palaszynski E; Fiskum G; Coy DH; Moody TW
Life Sci; 1989; 44(5):367-73. PubMed ID: 2536883
[TBL] [Abstract][Full Text] [Related]
17. Substance P-related antagonists inhibit vasopressin and bombesin but not 5'-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells.
Seckl MJ; Newman RH; Freemont PS; Rozengurt E
J Cell Physiol; 1995 Apr; 163(1):87-95. PubMed ID: 7534771
[TBL] [Abstract][Full Text] [Related]
18. Antagonism by GRP(18-27) and substance P analogues on insulin release stimulated by GRP(18-27).
Mukai H; Kawai K; Suzuki S; Yamashita K; Munekata E
Peptides; 1990; 11(1):173-5. PubMed ID: 1692992
[TBL] [Abstract][Full Text] [Related]
19. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
NyƩki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]